BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:27 PM
 | 
Feb 09, 2010
 |  BC Extra  |  Top Story

Novartis in-licenses Debio 025

Debiopharm S.A. (Lausanne, Switzerland) granted Novartis AG (NYSE:NVS; SIX:NOVN) exclusive, worldwide rights, excluding Japan, to...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >